SELARL PHARMACIE DEGRELLE DUBUC is a French company
founded 12 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-TROPEZ (83990),
this company of category PME
shows in 2016 a revenue of 2.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DEGRELLE DUBUC (SIREN 793544420)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
2 461 748 €
2 250 222 €
Net income
365 793 €
332 771 €
329 121 €
493 553 €
340 726 €
255 914 €
258 198 €
291 875 €
238 850 €
170 004 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
377 435 €
243 381 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
9.7%
7.6%
Revenue and income statement
In 2024, SELARL PHARMACIE DEGRELLE DUBUC generates positive net income of 366 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2024: 170 k€ -> 366 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
365 793 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 7%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 88%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
6.949%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
87.87%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
343.446
243.74
172.179
129.497
67.464
61.592
33.876
24.383
14.797
6.949
Financial autonomy
21.463
27.474
34.406
41.008
55.901
56.843
68.784
76.66
82.4
87.87
Repayment capacity
17.373
9.572
None
None
None
None
None
None
None
None
Cash flow / Revenue
6.569%
10.205%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
6.952024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent
In 2024, the debt ratio of SELARL PHARMACIE DEGRELLE... (6.95) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
87.87%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+13 pts over 3 years
In 2024, the financial autonomy of SELARL PHARMACIE DEGRELLE... (87.9%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 312.57. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
424.223
410.441
404.394
653.942
299.177
392.385
410.016
471.074
382.959
312.574
Interest coverage
21.082
12.684
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
312.572024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent
In 2024, the liquidity ratio of SELARL PHARMACIE DEGRELLE... (312.57) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE DEGRELLE DUBUC
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
411 521 €
499 587 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
28
29
0
0
0
0
0
0
0
0
Customer payment term (days)
10
13
0
0
0
0
161
0
0
0
Supplier payment term (days)
20
26
0
0
0
0
336
0
0
0
Positioning of SELARL PHARMACIE DEGRELLE DUBUC in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE DEGRELLE DUBUC is estimated at
5 106 740 €
(range 3 556 253€ - 7 639 976€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
3556k€5106k€7639k€
5 106 740 €Range: 3 556 253€ - 7 639 976€
NAF 5 année 2024
Valuation method used
Net Income Multiple
365 793 €
×
14.0x
=5 106 741 €
Range: 3 556 253€ - 7 639 976€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DEGRELLE DUBUC with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DEGRELLE DUBUC
What is the revenue of SELARL PHARMACIE DEGRELLE DUBUC ?
The revenue of SELARL PHARMACIE DEGRELLE DUBUC in 2016 is 2.5 M€.
Is SELARL PHARMACIE DEGRELLE DUBUC profitable?
Yes, SELARL PHARMACIE DEGRELLE DUBUC generated a net profit of 366 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE DEGRELLE DUBUC ?
The headquarters of SELARL PHARMACIE DEGRELLE DUBUC is located in SAINT-TROPEZ (83990), in the department Var.
Where to find the tax return of SELARL PHARMACIE DEGRELLE DUBUC ?
The tax return of SELARL PHARMACIE DEGRELLE DUBUC is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DEGRELLE DUBUC operate?
SELARL PHARMACIE DEGRELLE DUBUC operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart